MedPath

Venclose, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Venclose RF Ablation System for the Treatment of IPVs

Not Applicable
Completed
Conditions
Chronic Venous Insufficiency
First Posted Date
2020-05-13
Last Posted Date
2022-05-27
Lead Sponsor
Venclose, Inc.
Target Recruit Count
27
Registration Number
NCT04386785
Locations
🇺🇸

Vein Center of East Texas at CardioStream, Tyler, Texas, United States

EU Post Market Clinical Follow-Up Study of the Venclose System for Saphenous Vein Incompetence

Not Applicable
Completed
Conditions
Chronic Venous Insufficiency
First Posted Date
2020-01-22
Last Posted Date
2022-04-04
Lead Sponsor
Venclose, Inc.
Target Recruit Count
25
Registration Number
NCT04236245
Locations
🇩🇪

Venenzentrum am Bruehl, Leipzig, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.